RNA Leaders USA Congress 2023

AGC Biologics is a leading global Contract Development and Manufacturing Organization (CDMO), with a relentless commitment to deliver the highest standard of service to our clients and partners.

Founded in 2019, Arranta Bio is a visionary contract development and manufacturing organization (CDMO) that partners with companies seeking to develop and manufacture complex biological drugs and innovative therapies.

Artificial intelligence, augmented reality, Internet of Things – these are not just trends, they are drivers changing the way people live across the globe.

Exothera is a viral vector contract manufacturing and development organization (CDMO) using standard and innovative bioproduction platforms to rapidly deliver affordable viral vector-based vaccines and cell and gene therapies.

Here’s the deal. We’re all about helping biologics and gene therapy researchers break free from tools that just don’t cut it. Unleashing problem-tackling products that make a huge difference in the real science they do every day.

Abzu was born from the desire to challenge the fundamental assumptions of contemporary, black box AI.

For more than a century, we have stayed true to a core set of values – excellence, integrity, and respect for people – that guide us in all we do: discovering medicines that meet real needs, improving the understanding and management of disease, and

We manufacture biologics to the highest quality, meeting precise client requirements through smart investments and innovation.

Eclipsebio has developed multiple world-class RNA genomics products used by biopharma and academic customers around the world to map their RNA targets and RNA binding proteins with unmatched clarity.

NanoVation Therapeutics (NTx) is an early-stage gene therapy company developing next-generation platform technologies utilizing lipid nanoparticles for the safe and efficient delivery of nucleic acids to a variety of tissues.

Particle Works designs and builds game-changing particle engineering platforms that allow scientists to take complete control of their nanoparticle production process.

At ChemGenes, we redefine the limits of scientific discovery, development and commercialization by manufacturing the broadest range of modified chemistries available in today’s market.

PolyPeptide is a focused Contract Development & Manufacturing Organization (CDMO) for peptide- and oligonucleotide-based active pharmaceutical ingredients.

Hongene Biotech Corporation was established in 1998 as an R&D organization and has since become a manufacturer with state-of-art facilities in the fields of nucleosides, nucleotides and phosphoramidites. Having main operations in Shanghai, China at the start, today the company also has offices and l

Headquartered in Morrisville, NC, USA, Synoligo Biotechnologies was founded as a Contract Research Organization (CRO) specialized in manufacturing complicated, highly modified oligonucleotide to the academic, biotech and big pharmaceutical communities. Synoligo is a leading oligonucleotide manufactu

Glycogene LLC (Glycogene) is an advanced biotechnology enterprise founded in April 2019. The specialties of Glycogene are sugar-based products which include nucleotides, nucleosides, phosphoramidites, carbohydrates, and so on. Glycogene has more than 3,0000 sq ft of the research lab and a high-quali

We are a new Canadian CMO specializing in the production of nucleic acid products that support life-enabling work. We support our clients by providing scalable manufacturing capacity and help them accelerate innovation in bringing their products from benchtop to bedside or field.

Sylentis is an European biotechnological company founded in 2006. Sylentis focuses on researching new therapeutic approaches based on gene silencing. Our company is specialised in developing ophtalmologic therapies via interference RNA, a powerful tool for rational drug design.

4basebio is enabling next generation cell and gene therapies and vaccines with its technologies and solutions. We are able to design, manufacture and supply application-specific synthetic DNA or mRNA as well as targeted non-viral vectors for the delivery of nucleic acid payloads.

Momentum was founded in 2008 to develop rapid tests for critically-important clinical specimens within the hospital microbiology laboratory. The Company is backed by its founders, business angels and venture capital. Momentum is headquartered near Cardiff and has a R&D facility near Oxford in the UK